PALO ALTO, CA, Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company, has closed $131 million in Series B financing. Read More
PORTLAND, OR, PreAct Technologies, a market leader in near-field software-definable flash LiDAR technology, has announced a $14 million first close of its Series B funding. Read More